Abstract Objectives The European Society for Clinical and Economic Aspects of
Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) sought to revisit the …

Importance Even though osteoarthritis is a chronic and progressive disease,
pharmacological agents are mainly studied over short-term periods, resulting in unclear …

Background Chitin and chitosan are natural biopolymers found in shell of crustaceans,
exoskeletons of insects and mollusks, as well as in the cell walls of fungi. These biopolymers …

Osteoarthritis is thought to be the most prevalent chronic joint disease. The incidence of
osteoarthritis is rising because of the ageing population and the epidemic of obesity. Pain …

Abstract The European Society for Clinical and Economic Aspects of Osteoporosis and
Osteoarthritis (ESCEO) published a treatment algorithm for the management of knee …

Background There is no cure for knee osteoarthritis (KOA) and typically patients live
approximately 30-years with the disease. Most common medical treatments result in short …

OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 …

The increased information provided by modern imaging has led to its more extensive use.
Our aim was to develop evidence-based recommendations for the use of imaging in the …

PURPOSE: To develop concise, patient-focussed, up to date, evidence-based, expert
consensus recommendations for the management of hip and knee osteoarthritis (OA), which …

Osteoarthritis (OA) is the most common joint disease and a leading cause for impaired
function and disability with significant treatment costs and socio-economic burden. Despite …